Circulating MrgD in Pulmonary Hypertension

NCT06365372 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2024-04-15

No results posted yet for this study

Summary

The aim of the study is to observe the change of the circulating MrgD level in patients with pulmonary hypertension compared with subjects without pulmonary hypertension.

Conditions

  • Pulmonary Hypertension

Interventions

DIAGNOSTIC_TEST

Western blot

Samples were measured by Western blot using a solution for the separation of lymphocytes from peripheral blood.

Sponsors & Collaborators

  • Qilu Hospital of Shandong University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-10
Primary Completion
2024-05-10
Completion
2024-06-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06365372 on ClinicalTrials.gov